JPH0251914B2 - - Google Patents

Info

Publication number
JPH0251914B2
JPH0251914B2 JP57123732A JP12373282A JPH0251914B2 JP H0251914 B2 JPH0251914 B2 JP H0251914B2 JP 57123732 A JP57123732 A JP 57123732A JP 12373282 A JP12373282 A JP 12373282A JP H0251914 B2 JPH0251914 B2 JP H0251914B2
Authority
JP
Japan
Prior art keywords
methylflavone
group
carboxylate
piperidino
compound according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP57123732A
Other languages
English (en)
Japanese (ja)
Other versions
JPS5835185A (ja
Inventor
Narudei Dante
Tajana Aruberuto
Peniini Renzo
Kazuraani Pietoro
Guratsuiani Gaburiere
Kasadeio Shirubano
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
REKORUDACHI SA
Original Assignee
REKORUDACHI SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by REKORUDACHI SA filed Critical REKORUDACHI SA
Publication of JPS5835185A publication Critical patent/JPS5835185A/ja
Publication of JPH0251914B2 publication Critical patent/JPH0251914B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/28—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
    • C07D311/30—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only not hydrogenated in the hetero ring, e.g. flavones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C07D451/06—Oxygen atoms
    • C07D451/12—Oxygen atoms acylated by aromatic or heteroaromatic carboxylic acids, e.g. cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Neurosurgery (AREA)
  • Endocrinology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
JP57123732A 1981-07-17 1982-07-14 ３−メチルフラボン−８−カルボン酸エステル類 Granted JPS5835185A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8122158 1981-07-17
GB8122158 1981-07-17

Publications (2)

Publication Number Publication Date
JPS5835185A JPS5835185A (ja) 1983-03-01
JPH0251914B2 true JPH0251914B2 (en, 2012) 1990-11-08

Family

ID=10523330

Family Applications (1)

Application Number Title Priority Date Filing Date
JP57123732A Granted JPS5835185A (ja) 1981-07-17 1982-07-14 ３−メチルフラボン−８−カルボン酸エステル類

Country Status (25)

Country Link
US (1) US4550115A (en, 2012)
EP (1) EP0072620B1 (en, 2012)
JP (1) JPS5835185A (en, 2012)
KR (1) KR870000275B1 (en, 2012)
AR (1) AR231543A1 (en, 2012)
AT (1) ATE16806T1 (en, 2012)
AU (1) AU553322B2 (en, 2012)
CA (1) CA1221969A (en, 2012)
DE (1) DE3267782D1 (en, 2012)
DK (1) DK160498C (en, 2012)
ES (1) ES8400109A1 (en, 2012)
FI (1) FI73677C (en, 2012)
GB (1) GB2104507B (en, 2012)
GR (1) GR81300B (en, 2012)
HU (1) HU189601B (en, 2012)
IE (1) IE53525B1 (en, 2012)
IL (1) IL66187A0 (en, 2012)
IT (1) IT1198389B (en, 2012)
NO (1) NO157330C (en, 2012)
NZ (1) NZ200981A (en, 2012)
PH (1) PH18001A (en, 2012)
PT (1) PT75230B (en, 2012)
SG (1) SG77784G (en, 2012)
YU (2) YU136682A (en, 2012)
ZA (1) ZA824335B (en, 2012)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58225083A (ja) * 1982-06-23 1983-12-27 Nippon Shinyaku Co Ltd メチルフラボン誘導体
FI74707C (fi) * 1982-06-29 1988-03-10 Sandoz Ag Foerfarande foer framstaellning av terapeutiskt anvaendbara alkylenoeverbryggade piperidylestrar eller -amider av bicykliska karboxylsyror.
IT1229856B (it) * 1989-04-20 1991-09-13 Recordati Chem Pharm Compresse a rilascio controllato contenenti flavossato.
US5474994A (en) * 1992-05-26 1995-12-12 Recordati S.A., Chemical And Pharmaceutical Company Bicyclic heterocyclic derivatives having α1 -adrenergic and 5HT1A
US5605896A (en) * 1992-02-25 1997-02-25 Recordati S.A., Chemical And Pharmaceutical Company Bicyclic heterocyclic derivatives having α1 adrenergic and 5HT1A activities
SG65570A1 (en) 1992-02-25 1999-06-22 Recordati Chem Pharm Heterobicyclic compounds
IT1254469B (it) * 1992-02-25 1995-09-25 Recordati Chem Pharm Derivati benzopiranici e benzotiopiranici
IT1258315B (it) * 1992-04-10 1996-02-22 Recordati Chem Pharm Derivati del flavone
US6087366A (en) * 1996-03-07 2000-07-11 The Trustees Of Columbia University In The City Of New York Use of flavopiridol or a pharmaceutically acceptable salt thereof for inhibiting cell damage or cell death
US7501443B2 (en) 2002-12-23 2009-03-10 Ranbaxy Laboratories Limited Flavaxate derivatives as muscarinic receptor antagonists

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2921070A (en) * 1957-11-05 1960-01-12 Recordati Lab Farmacologico S Basic esters of 3-methylflavone-8-carboxylic acid
US4217351A (en) * 1976-08-04 1980-08-12 Abbott Laboratories Benzopyrano quinuclidines useful as antiglaucoma agents

Also Published As

Publication number Publication date
KR840000521A (ko) 1984-02-25
PH18001A (en) 1985-02-28
KR870000275B1 (ko) 1987-02-23
NO157330B (no) 1987-11-23
NO822127L (no) 1983-01-18
ATE16806T1 (de) 1985-12-15
FI822493A0 (fi) 1982-07-13
AU553322B2 (en) 1986-07-10
GR81300B (en, 2012) 1984-12-11
YU136682A (en) 1985-06-30
NZ200981A (en) 1984-10-19
GB2104507A (en) 1983-03-09
ES513993A0 (es) 1983-10-16
IE821678L (en) 1983-01-17
FI73677B (fi) 1987-07-31
SG77784G (en) 1985-04-26
YU125184A (en) 1985-04-30
NO157330C (no) 1988-03-02
IT8222274A0 (it) 1982-07-07
FI73677C (fi) 1987-11-09
JPS5835185A (ja) 1983-03-01
HU189601B (en) 1986-07-28
DK160498C (da) 1991-08-26
PT75230A (fr) 1982-08-01
EP0072620B1 (en) 1985-12-04
FI822493L (fi) 1983-01-18
IL66187A0 (en) 1982-11-30
PT75230B (fr) 1984-07-23
ZA824335B (en) 1983-05-25
US4550115A (en) 1985-10-29
IE53525B1 (en) 1988-12-07
IT1198389B (it) 1988-12-21
GB2104507B (en) 1984-09-19
DE3267782D1 (en) 1986-01-16
AR231543A1 (es) 1984-12-28
ES8400109A1 (es) 1983-10-16
DK160498B (da) 1991-03-18
CA1221969A (en) 1987-05-19
EP0072620A1 (en) 1983-02-23
AU8609882A (en) 1983-01-20
DK301982A (da) 1983-01-18

Similar Documents

Publication Publication Date Title
US5130311A (en) Oxazolopyridine compounds, compositions and use
US4675319A (en) Antianaphylactic and antibronchospastic piperazinyl-(N-substituted phenyl)carboxamides, compositions and use
JPH0251914B2 (en, 2012)
US4578392A (en) Pyrazolo[1,5-a]pyridine derivatives and anti-allergic compositions containing them
JPH0273081A (ja) 抗潰瘍性（アルキルジチオ）キノリン誘導体
JPS58188876A (ja) 抗炎症剤及び抗喘息剤
US4690933A (en) Pyridylvinyl-1H tetrazole having antihistamine activity
JPS588379B2 (ja) パラ−イソプチルヒドロアトロバ酸誘導体およびその製法
EP0069527B1 (en) Cystine derivatives
EP0133534B1 (en) Pyridyl compounds
EP0238982B1 (en) Anticholinergic compounds, pharmaceutical compositions and method of treatment
JPS5810387B2 (ja) ４，５，６，７テトラヒドロイミダゾ〔４，５−ｃ〕ピリジン誘導体及びその製法
AU627609B2 (en) New quinoline derivatives and process for the preparation thereof
EP0693494B1 (en) Phosphorylated derivatives of compounds having anti-inflammatory or analgesic activity
WO1991001315A1 (en) New quinoline derivatives and process for the preparation thereof
KR20020058036A (ko) 2-아릴퀴놀린 유도체, 그의 제조 방법 및 치료제로서의 용도
EP0486211A1 (en) Isoquinoline derivatives
JPH01121274A (ja) ２−置換シクロヘプトイミダゾール誘導体、抗潰瘍剤並びにその製法
JPH0432074B2 (en, 2012)
JPS6183172A (ja) ジベンゾ〔ｂ，ｆ〕〔１，５〕オキサゾシン誘導体及びその製造法並びにそれを有効成分とする医薬
JPS6360743B2 (en, 2012)
JPS63222151A (ja) ２−プロピルアミン誘導体、その製造方法およびそれを含有する医薬組成物
JPS60169472A (ja) 新規なフエニルピペラジン誘導体
JPH0639473B2 (ja) ８−アシルオキシエチルピロリチジンおよび第４級アンモニウム塩
JPS61145144A (ja) ５，８−ジヒドロキシ−１，４−ナフトキノン誘導体およびそれを含有する医薬